Interní Med. 2006; 8(10): 447-450

Pharmacotherapy in pregnancy

MUDr. Tomáš Binder CSc
Gynekologicko-porodnická klinika, 2. LF a FN v Motole, Univerzita Karlova v Praze

The article presents the review of specificity of drug administration in various stages in pregnancy. In farther part the article adjudicates the drugs from the viewpoint of their teratogenicity and maleficence during the fetal developmental period. The general recommendations for pharmacotherapy in women in fertile age and during pregnancy and the review of recommended drugs in most frequent diseases are adduced in the end of the article.

Keywords: Key words: pharmacotherapy, pregnancy.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Binder T. Pharmacotherapy in pregnancy. Interní Med. 2006;8(10):447-450.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Andrews EB, Yankansas BC, Cordeto JE et al. Acyklovir in pregnancy registry: Six years experience. Obstet Gynecol 1992: 79; 7. Go to PubMed...
    2. Briggs GG, Freeman RK, Yafe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 7th Edition Lippincott Williams and Wilkins, 2005.
    3. Creasy RK, Resnik R. Maternal - Fetal Medicine: Priciples and Practice 5th Edition, Saunders, Elsevier Inc. (USA) 2004.
    4. Diav-Citrin O,Schechtman S, Amon J et al. Pregnancy outcome after exposure to metronidazole: a prospective controlled cohort study. Teratology 2001: 63; 186. Go to original source... Go to PubMed...
    5. Gilbert C."Floppy syndrome" and maternal diazepam Lancet 1977; 2: 244. Go to original source... Go to PubMed...
    6. Holmes LB, Harvey EA, Coull BA et al. The teratogenicitity of anticonvulsant agents N Eng J Med; 2001; 344; 1132. Go to original source... Go to PubMed...
    7. Institute of Medicine. Nutrition during pregnancy and Lactation: An Implementation Guide. Subcommittee for a Clinical Application Guide, Committee on Nutritional Status during Pregnancy and Lacation, Food and Nutrition Board. Washington, DC, National Academy Press, 1992a.
    8. Institute of Medicine. Nutrition Services in Perinatal Care, Report of the Committee on Nutritional Status during Pregnancy and Lactation, Food and Nutrition Board. Washington, DC, National Academy Press, 1992b.
    9. Interim Report: 1/l /89-1/31/01. Wilmington, NC, Antiretroviral Pregnancy Registry. May 2001.
    10. Nelson K, Holmes LB. Malformations due to spontaneous mutations in newborn infants. N Eng J Med 1989; 320: 19. Go to original source... Go to PubMed...
    11. Paulus W. A practical guide to drugs in pregnancies Advanced ICAS Training Course on, ,Perinatal Management of High-Risk Pregnancies - a Rational Approach" October 2005, University Hospital Ulm, Germany.
    12. Rosenthal T, Oparil S. The effect of antihypertensive drugs on the fetus. J Hum Hyperten 2002; 16: 293. Go to original source... Go to PubMed...
    13. Scone JR, Heinonen O, Kaufman D et al. Aspirin and congenital malformations Lancet 1976; 1: 1373. Go to original source... Go to PubMed...
    14. Sheppard TH. The catalog of Teratogenic Agents, 9th ed. Baltimore, John Hopkins University Press,1998.
    15. Sheppard TH, Brent RI, Jones KI et al. Update on new developments in the study of human teratogens Teratology 2002; 65: 153. Go to original source... Go to PubMed...
    16. Van den Vayver IB, Moise KJ, Ou CN. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus Obstet Gynecol 1993; 82: 500. Go to original source... Go to PubMed...
    17. Watts DH. Management of the human immunodeficiency virus infection in pregnancy. N Eng J Med 2002; 346: 1879. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.